Speaker illustration

Associate Professor Michal Mazurek

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

Member of:

European Society of Cardiology
European Heart Rythm Association

Long-term outcome and mortality predictors in patients with extremely enlarged left ventricle end-diastolic diameter undergoing cardiac resynchronization therapy

Event: ESC Congress 2022

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Chronic heart failure - ICD, device and cardiac resynchronisation therapy

Thumbnail

10-year survival in patients undergoing cardiac resynchronization therapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Chronic heart failure e-posters

Thumbnail

10-year outcomes of triple-site versus standard cardiac resynchronization therapy randomized trial (TRUST CRT)

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Device Therapy ePosters

Thumbnail

Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

Event: ESC CONGRESS 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Outcomes in atrial fibrillation

Thumbnail

Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry

Event: ESC CONGRESS 2016

Topic: Primary care

Session: Best Posters in in transforming understanding of the elderly with cardiovascuclar disease

Thumbnail

This platform is supported by

logo Novo Nordisk